Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Alberta

$25,000.00

Investigation of peptides and peptidomimetics for developing bioactive molecules

EF 2011-12

Résumé
Peptides, or small fragments of proteins, have opened up immense possibilities for development of highly sensitive molecular and biological diagnostics, sensors with specific interaction and binding with numerous biomolecules, potential drugs, inhibitors, and food preservatives. However, natural alpha-peptides are frequently susceptible to proteolysis and metabolism, where they can be ""consumed"" or ""broken down"" by other biological entities before they reach their targets in a biologically active environment. Synthetic molecules that mimic natural peptides, but are conformationally and metabolically more stable, such as beta-peptides, are viable alternatives to natural peptides. These unnatural peptide-mimics or peptidomimetics can provide enhanced interaction with their target biological systems. The objectives of the proposed research are: a) design and synthesis of metabolically stable and biologically active peptidomimetics; and b) development of new methods to study peptide interactions in a variety of in vitro systems of biological, analytical, and environmental relevance. We will use automated (robotic) solid phase synthesis to design peptide arrays on cellulose membranes. Both alpha and beta peptide libraries will be synthesized from rational combinations of amino acids. Three scenarios of fundamental importance in peptide interactions or peptide binding will be studied. First, antibacterial peptide analogues will be designed, synthesized, and tested to mimic class IIa and IIb bacteriocins (which are potent antimicrobial peptides). Second, a model peptide based on a SARS virus receptor protein will be developed and tested as an embodiment of protein-protein interaction inhibitor. Third, a peptide array for identifying specific interactions with a Hepatitis C virus envelope protein will be developed to identify the most potent entry inhibitor. These three studies will provide a fundamental perspective of rational peptide design and synthesis for targeted applications. It is expected that this research will provide a broad-based platform for future development of peptide arrays as a viable tool for preparation of novel scaffolds for high-throughput studies of biological interactions.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
299433-2011
Name nom
Kaur, Kamaljit
Department département
Pharmacy and Pharmaceutical Science, Faculty of
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2011
Award amount
25000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3705
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Bio-organic chemistry
Research subject fr
Chimie bio-organique
Partie
1
Nb partie
5
Application title
Investigation of peptides and peptidomimetics for developing bioactive molecules
Keyword
NSERC
Application summary
Peptides, or small fragments of proteins, have opened up immense possibilities for development of highly sensitive molecular and biological diagnostics, sensors with specific interaction and binding with numerous biomolecules, potential drugs, inhibitors, and food preservatives. However, natural alpha-peptides are frequently susceptible to proteolysis and metabolism, where they can be ""consumed"" or ""broken down"" by other biological entities before they reach their targets in a biologically active environment. Synthetic molecules that mimic natural peptides, but are conformationally and metabolically more stable, such as beta-peptides, are viable alternatives to natural peptides. These unnatural peptide-mimics or peptidomimetics can provide enhanced interaction with their target biological systems. The objectives of the proposed research are: a) design and synthesis of metabolically stable and biologically active peptidomimetics; and b) development of new methods to study peptide interactions in a variety of in vitro systems of biological, analytical, and environmental relevance. We will use automated (robotic) solid phase synthesis to design peptide arrays on cellulose membranes. Both alpha and beta peptide libraries will be synthesized from rational combinations of amino acids. Three scenarios of fundamental importance in peptide interactions or peptide binding will be studied. First, antibacterial peptide analogues will be designed, synthesized, and tested to mimic class IIa and IIb bacteriocins (which are potent antimicrobial peptides). Second, a model peptide based on a SARS virus receptor protein will be developed and tested as an embodiment of protein-protein interaction inhibitor. Third, a peptide array for identifying specific interactions with a Hepatitis C virus envelope protein will be developed to identify the most potent entry inhibitor. These three studies will provide a fundamental perspective of rational peptide design and synthesis for targeted applications. It is expected that this research will provide a broad-based platform for future development of peptide arrays as a viable tool for preparation of novel scaffolds for high-throughput studies of biological interactions.